COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00923247
Brief Title: A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)

First Submitted : June 17, 2009
First Submitted that Met QC Criteria : June 17, 2009
First Posted : June 18, 2009 (Estimate)

Results First Submitted : January 23, 2017
Results First Submitted that Met QC Criteria : April 13, 2017
Results First Posted : May 17, 2017

Last Update Submitted that Met QC Criteria : November 5, 2018
Last Update Posted : November 29, 2018